mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

NCT06919796 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers
SARS CoV-2

Interventions

BIOLOGICAL: COMIRNATY®

Sponsor

PharmaJet, Inc.

Collaborators

[object Object]